KRISHNAMOHAN NEHA (Chief Financial Officer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/5/2023ACC: 0001209191-23-057455
Officer· Chief Financial Officer
Since Jun 2021
-1.46K
Net shares
Net seller
$3.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.46K
Price / share
$2.25
Trade value
$3.28K
% of position
2.2%
12/1/2023
67.05K→65.59K
Total
Net shares
−1.46K
Net value
-$3.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2023 | F · Tax Withholding | −1.46K | $2.25 | $3.28K | 2.2% | 67.05K | 65.59K |
| Total | −1.46K | -$3.28K | ||||||
Derivative Transactions0
No derivative transactions reported